• Tonix Pharmaceuticals CEO and director Seth Lederman purchased 5,000 shares of common stock at $4.055 per share.
• His direct holdings rose to 16,005 shares; indirect holdings totaled 20,002 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tonix Pharmaceuticals Holding Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-051200), on November 12, 2026, and is solely responsible for the information contained therein.